$0.953000
-0.06-5.64%
At close: -
$0.988000
0.043.67%
After Hours: 4:41 PM EDT
Comments
Loading...
I-MAB (NASDAQ:IMAB) Stock Quotes, Forecast and News Summary
I-MAB Stock (NASDAQ: IMAB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy I-MAB (IMAB) stock?
You can purchase shares of I-MAB (NASDAQ:IMAB) through any online brokerage.
Who are I-MAB (IMAB) competitors?
Other companies in I-MAB’s space includes: Renovaro (NASDAQ:RENB), Invizyne Technologies (NASDAQ:IZTC), Aligos Therapeutics (NASDAQ:ALGS), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for I-MAB (IMAB) stock?
I-MAB has a consensus price target of $12.25.
What is the current price for I-MAB (IMAB)?
The stock price for I-MAB (NASDAQ: IMAB) is $0.988 last updated November 19, 2024 at 4:41 PM EST.
Does I-MAB (IMAB) pay a dividend?
There are no upcoming dividends for I-MAB.
When is I-MAB (NASDAQ:IMAB) reporting earnings?
I-MAB’s H1 earnings are confirmed for Wednesday, August 28, 2024.
Is I-MAB (IMAB) going to split?
There is no upcoming split for I-MAB.
What sector and industry does I-MAB (IMAB) operate in?
I-MAB is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.